IGM Biosciences Inc (IGMS)
9.635
+0.44
(+4.73%)
USD |
NASDAQ |
May 15, 15:44
IGM Biosciences Cash and Short Term Investments (Quarterly): 293.77M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 293.77M |
| December 31, 2023 | 337.68M |
| September 30, 2023 | 386.99M |
| June 30, 2023 | 386.87M |
| March 31, 2023 | 373.40M |
| December 31, 2022 | 427.16M |
| September 30, 2022 | 469.14M |
| June 30, 2022 | 513.20M |
| March 31, 2022 | 187.46M |
| December 31, 2021 | 229.54M |
| September 30, 2021 | 259.51M |
| Date | Value |
|---|---|
| June 30, 2021 | 281.44M |
| March 31, 2021 | 331.67M |
| December 31, 2020 | 366.27M |
| September 30, 2020 | 180.24M |
| June 30, 2020 | 198.09M |
| March 31, 2020 | 206.77M |
| December 31, 2019 | 224.63M |
| September 30, 2019 | 242.08M |
| June 30, 2019 | 82.67M |
| December 31, 2018 | 1.887M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
82.67M
Minimum
Jun 2019
513.20M
Maximum
Jun 2022
298.93M
Average
287.61M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Akoya Biosciences Inc | 83.12M |
| Xilio Therapeutics Inc | 44.70M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |